IPO registrations (S-1, F-1) · Registrants
INTERMUNE INC
- SEC CIK
- 1087432 · filings on EDGAR ↗
- Name on the registration
- INTERMUNE PHARMACEUTICALS INC
- Former names
- INTERMUNE PHARMACEUTICALS INC (2000–2001)
- Registration
- Form S-1, first filed 2000-02-02, last 2000-09-08; 2 initial registrations, 5 amendments
- Outcome
- Final prospectus filed 2000-03-27
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 3280 BAYSHORE, BLVD, Brisbane, CA 94005
- EIN
- 94-3296648
- EDGAR entity type
- operating
- Insiders and CEO pay
- INTERMUNE INC on the corporate pages
Offering terms
- Proposed price range
- $17.00–$19.00 per share (S-1/A filed 2000-03-23)
- Final price
- $20.00 per share, above the range (424B1 filed 2000-03-27, an initial public offering)
- Shares sold
- 6,250,000
- Gross proceeds
- $125,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ITMN
- Lead underwriters
- UBS (2,250,000 shares); Prudential Securities (1,250,000 shares); J.P. Morgan (1,500,000 shares)
- Syndicate
- Hambrecht & Quist; Description of Graphics; Bear Stearns (165,000); Oppenheimer (165,000); Robertson Stephens (165,000); Lehman Brothers (165,000); Cowen (165,000); Pacific Growth Equities, Inc (165,000); Adams Harkness (65,000); Legg Mason (65,000); Piper Sandler (65,000); Truist Securities (65,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INTERMUNE, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: InterMune, Inc. Fuzzy (name and state)
- Business registration: INTERMUNE, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: INTERMUNE INC. EXACT (EIN (EXACT))
- Federal award recipient: INTERMUNE, INC. Fuzzy (name and state)
- Lobbying client: INTERMUNE, INC. Fuzzy (name and state)
- SEC filer: INTERMUNE INC EXACT (CIK (EXACT))
- Person page: William R Ringo Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other))
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-02-02 | S-1 | S-1 (registration) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-003537 ↗ |
| 2000-02-18 | S-1/A | S-1/A (amendment) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-007734 ↗ |
| 2000-03-06 | S-1/A | S-1/A (amendment) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-010052 ↗ |
| 2000-03-22 | S-1/A | S-1/A (amendment) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-012807 ↗ |
| 2000-03-23 | S-1/A | S-1/A (amendment) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-013053 ↗ |
| 2000-03-23 | S-1/A | S-1/A (amendment) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-013221 ↗ |
| 2000-03-24 | S-1MEF | S-1MEF (added securities) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-013282 ↗ |
| 2000-03-27 | 424B1 | 424B1 (final prospectus) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-013630 ↗ |
| 2000-09-08 | S-1 | S-1 (registration) | INTERMUNE PHARMACEUTICALS INC | 0000912057-00-040636 ↗ |
| 2001-06-29 | 424B1 | 424B1 (final prospectus) | INTERMUNE INC | 0000912057-01-522148 ↗ |
| 2001-06-29 | 424B1 | 424B1 (final prospectus) | INTERMUNE INC | 0000912057-01-522151 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-03-23 | S-1/A | registration statement | $17.00–$19.00 | 5,500,000 | - | Nasdaq ITMN | 5 | from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2000-03-27 | 424B1 | final prospectus | $20.00 | 6,250,000 | $125,000,000 | Nasdaq ITMN | 15 | from the submission text; price sentence, shares headline, proceeds table, underwriting table 13, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ARMSTRONG MARIANNE | Officer | Chief Med. Affairs/Reg. Off.; Chief Medical Affairs Officer; SVP Ch Reg & Drug Safety Off | 34 | 2006–2012 | |
| BLATT LAWRENCE | Officer; Other | Chief Scientific Officer | 12 | 2006–2008 | |
| Bradford Williamson Z III | Officer | SVP-Clinical Science; VP-Clinical Science; VP of Clinical Science | 35 | 2006–2012 | |
| Halleen Norman | Officer; Other | Former SVP of Finance & CFO; SVP, Finance and CFO | 9 | 2006 | |
| Kassberg Thomas Richard | Officer; Other | SVP, Corp. Dev. & Comm. Oper.; SVP-Corp. Dev.& Comm. Oper. | 12 | 2006–2007 | |
| Porter Steven Bryant | Officer | Chief Medical Officer | 36 | 2006–2012 | |
| Robinson Cynthia Y | Officer; Other | SVP, Development Operations; SVP-Dev. Operations | 9 | 2006–2007 | |
| Simon Howard Allan | Officer | SVP, Human Resources; SVP-Human Resources | 26 | 2006–2011 | |
| Steele Robin Joan | Officer | SVP and General Counsel; SVP, GC, Secretary; SVP, General Counsel | 33 | 2006–2013 | |
| HAWLEY ROGER | Other | 13 | 2006 | ||
| HEALY JAMES | Director | 17 | 2006–2014 | ||
| RINGO WILLIAM R | Director; Other | 4 | 2006–2008 | person page Fuzzy | |
| WELCH DANIEL G | Director,Officer | CEO and President; Chairman, CEO and President; Charman, CEO and President | 45 | 2006–2014 | |
| KABAKOFF DAVID S | Director | 16 | 2006–2014 | ||
| LEFF JONATHAN S | Director | 11 | 2006–2013 | ||
| SMITH MICHAEL L | Director | 2 | 2006–2007 | ||
| HODGMAN JOHN | Officer | EVP, Finance & CFO; EVP-Finance & CFO; SVP, Finance & CFO; SVP-Finance & CFO | 33 | 2006–2014 | |
| Ekman Lars | Director | 12 | 2006–2014 | ||
| HALTER WILLIAM A | Other | 7 | 2006 | ||
| HODGSON THOMAS R | Other | 2 | 2006 | ||
| DRAPEAU LOUIS | Director | 12 | 2007–2014 | ||
| Seiwert Scott | Officer | SVP, Rsch, Preclinical & CMC; SVP, Rsearch/ Preclinical Dev.; SVP, Rsearch & Technical Dev.; VP, Research/Preclinical Dev.; VP, Rsearch/ Preclinical Dev. | 22 | 2009–2012 | |
| Di Nepi Giacomo | Officer | EVP Managing Director, Europe; EVP, Managing Director, Europe; SVP, Managing Director, Europe | 15 | 2009–2014 | |
| Cohen Alan Howard | Officer | SVP, Medical Affairs | 9 | 2009–2012 | |
| KAYE CHARLES R | TenPercentOwner | 2 | 2010–2011 | ||
| LANDY JOSEPH | TenPercentOwner | 2 | 2010–2011 | ||
| WARBURG PINCUS & CO | Director,TenPercentOwner; TenPercentOwner | 2 | 2010–2011 | ||
| WARBURG PINCUS EQUITY PARTNERS LP | TenPercentOwner | 2 | 2010–2011 | ||
| WARBURG PINCUS LLC | TenPercentOwner | 2 | 2010–2011 | ||
| Warburg Pincus Partners LLC | Director,TenPercentOwner; TenPercentOwner | 2 | 2010–2011 | ||
| Russell Angus C. | Director | 7 | 2011–2014 | ||
| BIENAIME JEAN JACQUES | Director | 6 | 2012–2014 | ||
| Verwiel Frank | Director | 6 | 2012–2014 | ||
| Leff Jonathan A | Officer | EVP of R&D; EVP, Research & Development | 14 | 2012–2014 | |
| ARATA PAUL D | Officer | EVP, Human Resources & Admin; Executive VP of HR & Adm.; Senior VP of HR; Senior VP of HR & Adm. | 9 | 2012–2014 | |
| Nolan Sean P. | Officer | EVP & CBO; Executive VP & CBO | 12 | 2013–2014 | |
| Powell Andrew Kenneth William | Officer | EVP, GC & Corp. Secretary; EVP, GC & Secretary | 7 | 2013–2014 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | InterMune, Inc. | CA | State business registries | name and state |
| Business registration | INTERMUNE, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | INTERMUNE, INC. | CA | State business registries | name and state |
| Federal award recipient | INTERMUNE, INC. | CA | Federal spending (USAspending) | name and state |
| Lobbying client | INTERMUNE, INC. | CA | Federal lobbying (LDA) | name and state |
| Patent assignee | INTERMUNE, INC. | CA | Patents (USPTO) | name and state |
| SEC filer | INTERMUNE INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Intermune, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | INTERMUNE INC. | EIN (EXACT) | ||
| Person page | William R Ringo | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Other) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.